Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Clinical trial NCT00463073 · COMPLETED

Trial details

NCT number: NCT00463073
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Gliomas

Start date: 2006-08-01
Primary completion: 2008-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.